当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析

博瑞医药

(688166)

  

流通市值:212.76亿  总市值:212.76亿
流通股本:4.22亿   总股本:4.22亿

博瑞医药(688166)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-0.05亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益261601.69万元,未分配利润97379.90万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产528527.33万元,负债266925.64万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入248,959,843.431,282,551,614.5976,825,695.67657,688,446.99
营业总成本266,560,026.021,102,598,723.72798,339,394.77554,212,734.85
营业利润-11,896,358.17160,289,049.93168,350,913.5294,397,237.83
利润总额-11,863,878.89157,200,608.4168,076,343.1494,306,260.28
净利润-4,656,771.18141,263,284.54146,757,526.8482,226,988.64
其他综合收益-70,221.14-37,833,359.39-35,070,709.12-35,136,666.18
综合收益总额-4,726,992.32103,429,925.15111,686,817.7247,090,322.46
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,571,596,585.711,640,277,766.141,382,517,329.281,737,952,788.59
非流动资产合计3,713,676,711.13,524,068,391.343,496,015,482.523,492,715,373.25
资产总计5,285,273,296.815,164,346,157.484,878,532,811.85,230,668,161.84
流动负债合计938,194,263.591,052,385,357.52885,484,629.781,013,104,881.12
非流动负债合计1,731,062,179.251,674,584,936.831,650,708,519.231,803,420,334.28
负债合计2,669,256,442.842,726,970,294.352,536,193,149.012,816,525,215.4
归属于母公司股东权益合计2,501,618,781.222,394,647,560.622,352,381,122.672,387,662,549.13
股东权益合计2,616,016,853.972,437,375,863.132,342,339,662.792,414,142,946.44
负债和股东权益合计5,285,273,296.815,164,346,157.484,878,532,811.85,230,668,161.84
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计317,907,169.841,117,870,607.02904,023,277.15639,396,541.41
经营活动现金流出小计210,914,177.33872,311,289.92784,433,575.12488,176,192.29
经营活动产生的现金流量净额106,992,992.51245,559,317.1119,589,702.03151,220,349.12
投资活动现金流入小计6,160155,841,559.4298,281,859.0987,669,492.94
投资活动现金流出小计227,303,774.99595,983,083.56523,154,996.71379,415,238.28
投资活动产生的现金流量净额-227,297,614.99-440,141,524.14-424,873,137.62-291,745,745.34
筹资活动现金流入小计518,151,900926,077,074.15595,962,819.75516,062,819.75
筹资活动现金流出小计348,760,914.55950,551,978.01769,729,870.72400,369,380.25
筹资活动产生的现金流量净额169,390,985.45-24,474,903.86-173,767,050.97115,693,439.5
汇率变动对现金及现金等价物的影响3,123,026.272,118,247.621,333,672.341,913,878.09
现金及现金等价物净增加额52,209,389.24-216,938,863.28-477,716,814.22-22,918,078.63
期末现金及现金等价物余额806,311,320.19754,101,930.95493,323,980.01948,122,715.6
最新报告期:2025-04-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
德邦证券陈进,周新明0.600.700.862025-04-28
华西证券崔文亮0.510.540.642025-04-23
东方证券伍云飞0.610.710.812025-04-09
浙商证券孙建,盖文化,郭双喜0.440.490.622025-04-08
TOP↑